Literature DB >> 25054525

Evaluation of the use of a stabilization device to improve the quality of care in patients with peripherally inserted central catheters.

Jennifer Waterhouse1, Varsha Bandisode, Debra Brandon, Meredith Olson, Sharron L Docherty.   

Abstract

OBJECTIVES: This project evaluated the implementation of use of the StatLock stabilization device (Bard Access Systems, Inc, Salt Lake City, Utah) for peripherally inserted central catheters (PICCs) in pediatric cardiology patients. The aim was to implement the use of the StatLock device and evaluate its effects on the following 4 outcomes: incidence of dislodgement, infection, catheter dwell time, and the number of catheter replacements. The primary goal was to determine whether the StatLock device offered advantages over tape and sutures.
METHODS: A quality improvement design was used to evaluate whether the use of the StatLock stabilization device for PICC securement on 30 pediatric cardiology patients decreased the number of PICC complications compared with 30 historical comparison patients.
RESULTS: The comparison group had a significantly higher number of catheter dislodgements (n = 16; 59.3%) than the StatLock group (n = 8; 30.8%; P = .035). The comparison group did not have a significantly higher number of catheter replacements (n = 16; 59.3%) than the StatLock group (n = 10; 34.5%; P = .10). No significant differences were found in the rate of infection or in the catheter dwell time between the 2 groups (StatLock group, mean ± SD = 33.13 ± 22.71 days; comparison group, mean ± SD = 28.10 ± 24.83 days; P > .20).
CONCLUSIONS: Use of the StatLock device resulted in better outcomes when compared with the use of sutures, and it provided a more effective way to stabilize and secure PICCs.

Entities:  

Mesh:

Year:  2014        PMID: 25054525     DOI: 10.1097/NCI.0000000000000026

Source DB:  PubMed          Journal:  AACN Adv Crit Care        ISSN: 1559-7768


  4 in total

1.  [Case report on deviant care measures of a PICC line on a palliative patient].

Authors:  Günter Polt; Ingrid Bruchmann
Journal:  Wien Med Wochenschr       Date:  2019-04-23

2.  Peripherally inserted central venous catheters decrease central line-associated bloodstream infections and change microbiological epidemiology in adult hematology unit: a propensity score-adjusted analysis.

Authors:  Yosuke Nakaya; Mika Imasaki; Michinori Shirano; Katsujun Shimizu; Naoko Yagi; Minako Tsutsumi; Masahiro Yoshida; Takuro Yoshimura; Yoshiki Hayashi; Takafumi Nakao; Takahisa Yamane
Journal:  Ann Hematol       Date:  2022-07-02       Impact factor: 4.030

3.  Atrial fibrillation induced by peripherally inserted central catheters.

Authors:  Reshma Golamari; Yub Raj Sedhai; Karthik Ramireddy; Priyanka Bhattacharya
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-11-06

4.  SecurAstaP trial: securement with SecurAcath versus StatLock for peripherally inserted central catheters, a randomised open trial.

Authors:  Godelieve Alice Goossens; Niel Grumiaux; Christel Janssens; Martine Jérôme; Steffen Fieuws; Philip Moons; Marguerite Stas; Geert Maleux
Journal:  BMJ Open       Date:  2018-02-24       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.